UK-122

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameUK-122
Drug Alias NameUK-122
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUrokinase plasminogen activator stimulants
TargetsUrokinase plasminogen activator
Therapy Area/IndicationsPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTranslational Genomics Research Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTranslational Genomics Research Institute
Active IndicationsN/A
Inactive IndicationsPancreatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A